236 related articles for article (PubMed ID: 22324953)
1. South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.
Graf SW; Hakendorf P; Lester S; Patterson K; Walker JG; Smith MD; Ahern MJ; Roberts-Thomson PJ
Int J Rheum Dis; 2012 Feb; 15(1):102-9. PubMed ID: 22324953
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies in systemic sclerosis.
Steen VD
Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
4. Survival in scleroderma: results from the population-based South Australian Register.
Hissaria P; Lester S; Hakendorf P; Woodman R; Patterson K; Hill C; Ahern MJ; Smith MD; Walker JG; Roberts-Thomson PJ
Intern Med J; 2011 May; 41(5):381-90. PubMed ID: 20546058
[TBL] [Abstract][Full Text] [Related]
5. Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy.
Selva-O'Callaghan A; Labrador-Horrillo M; Solans-Laque R; Simeon-Aznar CP; Martínez-Gómez X; Vilardell-Tarrés M
Arthritis Rheum; 2006 Oct; 55(5):791-8. PubMed ID: 17013837
[TBL] [Abstract][Full Text] [Related]
6. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
[TBL] [Abstract][Full Text] [Related]
7. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement.
Mitri GM; Lucas M; Fertig N; Steen VD; Medsger TA
Arthritis Rheum; 2003 Jan; 48(1):203-9. PubMed ID: 12528120
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of autoantibody screening in patients with autoimmune myositis.
Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement.
Kaji K; Fertig N; Medsger TA; Satoh T; Hoshino K; Hamaguchi Y; Hasegawa M; Lucas M; Schnure A; Ogawa F; Sato S; Takehara K; Fujimoto M; Kuwana M
Arthritis Care Res (Hoboken); 2014 Apr; 66(4):575-84. PubMed ID: 24023044
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.
Koenig M; Fritzler MJ; Targoff IN; Troyanov Y; Senécal JL
Arthritis Res Ther; 2007; 9(4):R78. PubMed ID: 17688695
[TBL] [Abstract][Full Text] [Related]
11. Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma.
Ceribelli A; Cavazzana I; Franceschini F; Airò P; Tincani A; Cattaneo R; Pauley BA; Chan EK; Satoh M
J Rheumatol; 2010 Oct; 37(10):2071-5. PubMed ID: 20682663
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study.
Rozman B; Cucnik S; Sodin-Semrl S; Czirják L; Varjú C; Distler O; Huscher D; Aringer M; Steiner G; Matucci-Cerinic M; Guiducci S; Stamenkovic B; Stankovic A; Kveder T
Ann Rheum Dis; 2008 Sep; 67(9):1282-6. PubMed ID: 18063672
[TBL] [Abstract][Full Text] [Related]
13. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
[TBL] [Abstract][Full Text] [Related]
14. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma.
Danielides S; Mavragani CP; Katsakoulas I; Zintzaras E; Drosos AA; Vlachoyiannopoulos PG; Moutsopoulos HM
Scand J Rheumatol; 2011; 40(4):299-303. PubMed ID: 21417550
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis.
Hudson M; Mahler M; Pope J; You D; Tatibouet S; Steele R; Baron M; ; Fritzler M
J Rheumatol; 2012 Apr; 39(4):787-94. PubMed ID: 22467948
[TBL] [Abstract][Full Text] [Related]
17. HLA markers for susceptibility and expression in scleroderma.
Gladman DD; Kung TN; Siannis F; Pellett F; Farewell VT; Lee P
J Rheumatol; 2005 Aug; 32(8):1481-7. PubMed ID: 16078323
[TBL] [Abstract][Full Text] [Related]
18. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
[TBL] [Abstract][Full Text] [Related]
19. Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation.
Roberts-Thomson PJ; Walker JG; Lu TY; Esterman A; Hakendorf P; Smith MD; Ahern MJ
Intern Med J; 2006 Aug; 36(8):489-97. PubMed ID: 16866652
[TBL] [Abstract][Full Text] [Related]
20. [Anti PM-Scl antibodies. Study of prevalence and of meaning].
Gaudin C; Fortenfant F; Adoue D; Beyne-Rauzy O
Rev Med Interne; 2006 Sep; 27(9):665-70. PubMed ID: 16797795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]